ClinicalTrials.Veeva

Menu

Small Fiber Assessment by Cutaneous Silent Period

Cairo University (CU) logo

Cairo University (CU)

Status

Unknown

Conditions

Small Fiber Neuropathy

Treatments

Diagnostic Test: cutaneous silent period

Study type

Observational

Funder types

Other

Identifiers

NCT04863820
Clinical Neurophysiology

Details and patient eligibility

About

Our primary objective in this study is to investigate the cutaneous silent period (CSP) in normal subjects in the Egyptian population, as it was not carried out before in Egypt. The aim was to carry out the test in our unit to study the appropriate method, technique, and parameters of this new test so that we can apply it in future research. In addition, to obtain preliminary normative data of the test; onset latency, end latency, duration, and latency difference (LD) of CSP, as well as assess the effect of age, height, upper limb length, and gender on CSP values.

Full description

Nerve conduction studies performed routinely in electromyoneurography laboratories deal mainly with large myelinated fast conducting nerve fibers. A reliable method allowing the study of small peripheral nerve fibers (Aδ & C) would be of interest (Jovita et al., 2006). As they are initially affected and maybe the earliest exhibited sign of neuropathy.

In recent years, the cutaneous silent period (CSP) has received increased attention in health and disease. The CSP is an inhibitory spinal reflex that appears following strong electrical stimulation of the cutaneous nerve and causes suppression of voluntary muscular contraction for a certain period of time (Kofler et al., 2019). This action presents a reciprocal action to the nociceptive flexor withdrawal response (FWR) which serves as an 'excitatory reflex' increasing activity in primary flexor muscles. When taken into context, the interplay between the CSP and FWR can clearly be seen.

The evaluation of the CSP represents a useful electrophysiological method for investigating the function of small fibers by using standard electromyography equipment (Eckert et al., 2018).

Enrollment

64 estimated patients

Sex

All

Ages

20 to 60 years old

Volunteers

Accepts Healthy Volunteers

Inclusion criteria

  • Healthy participants able to cooperate and to follow instructions.
  • Participants having a normal value for electrophysiological parameters (Nerve conduction studies)
  • Participants must be free from any musculoskeletal impairment of the limbs

Exclusion criteria

  • Participants with neurological disorders
  • Participants with cognitive impairment
  • Participants receiving medications that may affect the NCS
  • Participants with small fiber neuropathy (burning sensation, pricking sensation, allodynia, and hyperalgesia)
  • Participants with an abnormal value for Nerve conduction studies
  • Participants with musculoskeletal impairment of the limbs

Trial contacts and locations

1

Loading...

Central trial contact

Lamia M Afifi, Professor; Sarah M Kaddah, MSc

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems